Forte Biosciences Inc. has approved an equity award for a new non-executive employee, granting options to purchase 75,000 shares of common stock. The stock options will vest over four years, with 25% vesting after the first year of employment and the remaining 75% vesting in equal monthly installments over the following three years, contingent on continued employment. The award was granted under the company's 2020 Inducement Equity Incentive Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Forte Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251222851400) on December 22, 2025, and is solely responsible for the information contained therein.